Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -6,598 | 30,900 |
| Depreciation Amortization | 700 | 2,870 |
| Accounts receivable | -2,456 | N/A |
| Other Working Capital | -11,421 | -57,310 |
| Other Operating Activity | 3,197 | 2,780 |
| Operating Cash Flow | $-16,578 | $-20,760 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -158 | -160 |
| Other Investing Activity | 0 | 27,860 |
| Investing Cash Flow | $-158 | $27,700 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | -2,330 | N/A |
| Other Financing Activity | 0 | -7,170 |
| Financing Cash Flow | $-2,330 | $-7,170 |
| Beginning Cash Position | 28,431 | 28,670 |
| End Cash Position | 9,364 | 28,430 |
| Net Cash Flow | $-19,067 | $-240 |
| Free Cash Flow | ||
| Operating Cash Flow | -16,578 | -20,760 |
| Capital Expenditure | -158 | N/A |
| Free Cash Flow | -16,737 | -20,760 |